Brean Capital Downgrades Viacom (VIAB) to Hold; Merger with CBS Does Not Maximize Value
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Analyst Alan Gould commented, "We are lowering our rating on Viacom to Hold from Buy and our fair value estimate becomes $40 from a TP of $44, the expected value in our VIA/CBS scenario analysis. We are lowering our probability of a CBS/VIA merger to 40% from 60% as we question the true synergies between the companies, and lowering our FY17 EPS estimate to $3.65 from $3.80. Our $40 fair value estimate equals 11x EPS, 9x EV/EBITDA and a 7% free cash flow yield based on our FY17 estimates which are somewhat below Street consensus."
Shares of Viacom closed at $38.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rite Aid (RAD)/Walgreens (WBA) Antitrust Concerns Doesn't Mean Deal is Dead, Says Deutsche Bank
- UPDATE: Viacom's (VIAB) Paramount, Shanghai Film, Huahua Sign Agreement to Co-Finance Slate of Films - Deadline.com
- PacWest Bancorp (PACW) PT Raised to $60.50 at FIG Partners Following 4Q Report
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Downgrades, Mergers and Acquisitions, Rumors
Related EntitiesDefinitive Agreement, Brean Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!